The result of this process includes the regulation of glucose transporters and expression of glycolytic enzymes, regulation of oxidative phosphorylation via TCA cycle and lipogenesis in VHL-lacking RCC patients [36,37]. This evidence concerns the gene VHL and renal cell carcinoma.